The NIH has awarded $40 million to Mayo Clinic to develop a comprehensive biorepository as the source of clinical samples for long COVID research studies.

Representing Mayo Clinic at the event, Dr. William Morice contributed his expertise and experience as leaders from around the world redoubled their commitment to end the COVID-19 pandemic.

Director of Mayo Clinic’s Infectious Diseases Serology Laboratory, Elitza Theel, Ph.D., joins a discussion about COVID-19 antibody testing in a recent story on NPR.

Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-class laboratory testing and resources to industry partners conducting clinical research and trials.

In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., reviews the results of a study that Mayo Clinic recently published comparing four different rapid antigen tests for novel coronavirus.